Plain-English translation of NCT06640660 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Multiple Sclerosis research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new approach called MindLenses that combines two types of treatment: prismatic adaptation (special eye exercises) and serious games (brain-training computer programs). The study includes people diagnosed with either West Nile virus infection or multiple sclerosis who have experienced problems with memory, attention, or everyday activities. Researchers want to see if this combined treatment can help improve thinking abilities and mood better than standard brain training alone.
Both West Nile virus and multiple sclerosis can damage the brain and cause difficulties with thinking, memory, attention, and mood—sometimes making it hard for people to do daily activities. Currently, standard brain training is offered, but doctors are looking for better ways to help patients recover thinking skills faster and more completely.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will be randomly placed into one of two groups. One group will receive 10 sessions over 2 weeks of the new MindLenses treatment, which includes eye exercises followed by about 30 minutes of brain-training games focused on attention and thinking skills. The other group will receive the standard brain training currently offered by the hospital. All participants will be closely monitored to see how their thinking abilities and mood improve.
AI-generated summary from trial data · Jun 25, 2026 · Not medical advice
Italy